Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease metabolic syndrome x
Symptom C0023895|liver disease
Sentences 54
PubMedID- 26064107 Other metabolic risk factors, such as the presence of metabolic syndrome, are associated with more severe liver disease 8.
PubMedID- 24044566 Aim: to investigate the relationship of adiponectin, leptin, resistin and rbp4 levels in obese and metabolic syndrome children with nonalcoholic fatty liver disease (nafld).
PubMedID- 26175982 Background: nonalcoholic fatty liver disease (nafld) is one of the aspects of metabolic syndrome (mets).
PubMedID- 20645852 The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome.
PubMedID- 20385429 Re: soft drink consumption is associated with fatty liver disease independent of metabolic syndrome.
PubMedID- 22135029 It is important to analyse the morphologic spectrum of bile duct changes in non-biliary diseases as a link has been reported between intrahepatic cholangiocarcinoma and chronic liver disease associated with viral hepatitis, metabolic syndromes and with alcohol abuse.
PubMedID- 24793377 In conclusion, in contrast to bpa, bps does not appear to induce the metabolic syndrome that may lead to non-alcoholic fatty liver disease (nafld), in vitro.
PubMedID- 20158939 Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome.
PubMedID- 24850609 Effect of gene polymorphism of ppargamma2 regulatory proteins on the metabolic syndrome in children with nonalcoholic fatty liver disease and obesity.
PubMedID- 22844333 Nonalcoholic fatty liver disease is associated with metabolic syndrome.
PubMedID- 25911912 Characteristics of the gastrointestinal myoelectrical activity in patients with nonalcoholic fatty liver disease associated with metabolic syndrome.
PubMedID- 25430922 A novel animal model of metabolic syndrome with non-alcoholic fatty liver disease and skin inflammation.
PubMedID- 25988570 Associations between dietary intake and the presence of the metabolic syndrome in patients with non-alcoholic fatty liver disease.
PubMedID- 26120587 Nonalcoholic fatty liver disease relationship with metabolic syndrome in class iii obesity individuals.
PubMedID- 23624251 Furthermore, a non-invasive method that allows quantification of specific lipid species could help differentiate patients with lal deficiency from patients with non-alcoholic fatty liver disease (nafld) due to metabolic syndrome.
PubMedID- 22813407 Association of nonalcoholic fatty liver disease with metabolic syndrome in indian population.
PubMedID- 24142602 Background and objectives: non-alcoholic fatty liver disease (nafld) is one of the most common metabolic syndromes and is characterized by the accumulation of hepatic triglycerides (tg), which result from an imbalance between uptake, synthesis, export, and oxidation of fatty acids.
PubMedID- 21387764 Non-alcoholic fatty liver disease (nafld) in patients with metabolic syndrome and type 2 diabetes mellitus.
PubMedID- 24665862 Management of fatty liver disease with the metabolic syndrome.
PubMedID- 22824769 The study therefore highlights the need to educate physicians on how to diagnose cirrhosis non-invasively and correlate features of metabolic syndrome with chronic liver disease.
PubMedID- 23842720 Non-alcoholic steatohepatitis (nash) is the progressive phenotype of non-alcoholic fatty liver disease associated with the metabolic syndrome.
PubMedID- 26399788 Nonalcoholic fatty liver disease is associated with metabolic syndrome and has the unique characteristic of excess lipid accumulation in liver.
PubMedID- 22644007 Prevalence of nonalcoholic fatty liver disease in subjects with metabolic syndrome.
PubMedID- 24531850 Evolving information suggests that the metabolic syndrome with non-alcoholic liver disease may be an important cause of hcc in addition to viral hepatitis and alcohol-induced liver disease.
PubMedID- 24933975 Efficiency of ursodeoxycholic acid therapy in non-alcoholic fatty liver disease associated with metabolic syndrome.
PubMedID- 23077931 The central role of the non alcoholic fatty liver disease in metabolic syndrome.
PubMedID- 24834224 The mean body mass index of the 22 cases was 31.18 ±5.7 and non-alcoholic fatty liver disease was associated with the metabolic syndrome in these subjects.
PubMedID- 22884916 Background: nonalcoholic fatty liver disease is closely associated with metabolic syndrome and cardiovascular disease (cvd).
PubMedID- 21118396 Background: moderate alcohol consumption may have certain beneficial effects against non-alcoholic fatty liver disease, which is associated with metabolic syndrome.
PubMedID- 24665369 found that serum zag concentrations were the only independent predictor of the number of metabolic syndrome components in patients with nonalcoholic fatty liver disease (nafld) after stepwise linear regression analysis.
PubMedID- 24496399 Cardiovascular disease (cvd) and non-alcoholic fatty liver disease (nafld) are manifestations of the metabolic syndrome.
PubMedID- 25947379 Non-alcoholic fatty liver disease is associated with metabolic syndrome and is becoming one of the most common forms of liver disease worldwide.
PubMedID- 25738756 Moreover, metabolic syndrome is intricately associated with non-alcoholic fatty liver disease 2.
PubMedID- 21413092 Obesity, which is related to metabolic syndrome and is associated with liver disease, represents an epidemic problem demanding effective therapeutic strategies.
PubMedID- 23355910 Is nonalcoholic fatty liver disease the hepatic expression of the metabolic syndrome.
PubMedID- 24141383 Within the transplant group, there was no significant association between mean telomere length and underlying liver disease or presence of the metabolic syndrome or its constituents.
PubMedID- 23066331 Fatty liver, including non-alcoholic fatty liver disease, is closely associated with metabolic syndrome (ms).
PubMedID- 25926979 The presence of multiple features of the metabolic syndrome is associated with progressive liver disease .
PubMedID- 24845607 Background & aims: non-alcoholic-fatty-liver disease (nafld) is part of the metabolic syndrome.
PubMedID- 22546752 Gamma-glutamyl transferase: a marker of nonalcoholic fatty liver disease in patients with the metabolic syndrome.
PubMedID- 19880582 Accumulating trans-sectional evidence suggests that the presence of multiple metabolic disorders, including obesity, diabetes, dyslipidemia, hypertension, and ultimately metabolic syndrome, are associated with nonalcoholic fatty liver disease (nafld) (1).
PubMedID- 24765691 An association of non-alcoholic fatty liver disease with insulin resistant metabolic syndrome and hypothyroidism has been suggested.
PubMedID- 23419204 Objective: while nonalcoholic fatty liver disease (nafld) is associated with the metabolic syndrome, it is not known if nafld plays an independent role in the atherogenic dyslipidemia phenotype.
PubMedID- 24280560 Non-alcoholic fatty liver disease; a part of the metabolic syndrome in the renal transplant recipient and possible cause of an allograft dysfunction.
PubMedID- 24713801 Background: although non-alcoholic fatty liver disease (nafld) is associated with obesity and metabolic syndrome (ms), it may also be present in lean individuals.
PubMedID- 21212755 Nonalcoholic fatty liver disease is associated with the metabolic syndrome.
PubMedID- 20817302 Nonalcoholic fatty liver disease: the hepatic trigger of the metabolic syndrome.
PubMedID- 23897104 Background: the association of plasma cardiovascular risk markers and metabolic syndrome (mets) with non-alcoholic fatty liver disease (nafld) has not been well defined.
PubMedID- 24000461 Strengthen the research and management of the relationship of liver diseases with metabolic syndrome.
PubMedID- 21040936 The metabolic syndrome is associated with nonalcoholic fatty liver disease (nafld) as well as with insulin resistance, inflammatory adipokines, endothelial dysfunction, and higher plasma levels of nonesterified fatty acids (nefa), all of which may also affect the development of nafld.

Page: 1 2